Factors affecting endoscopic treatment’s failure for primary vesicoureteral reflux in the paediatric population

1. Ellsworth, P, Yates, JK, Caldamone, AA. Presence of dextranomer-hyaluronic acid (DxHA) mound on postoperative ultrasound does not predict resolution of vesicoureteral reflux. J Pediatr Urol 2011; 7: 438–440.
Google Scholar | Crossref | Medline2. Dogan, HS, Altan, M, Citamak, B, et al. Factors affecting the success of endoscopic treatment of vesicoureteral reflux and comparison of two dextranomer based bulking agents: Does bulking substance matter? J Pediatr Urol 2015; 11: 90.e1–90.e5.
Google Scholar | Crossref3. Kobelt, G, Canning, DA, Hensle, TW, et al. The cost-effectiveness of endoscopic injection of dextranomer/hyaluronic acid copolymer for vesicoureteral reflux. J Urol 2003; 169: 1480–1484; discussion 1484–1485.
Google Scholar | Crossref | Medline4. Puri, P, Kutasy, B, Colhoun, E, et al. Single center experience with endoscopic subureteral dextranomer/hyaluronic acid injection as first line treatment in 1,551 children with intermediate and high grade vesicoureteral reflux. J Urol 2012; 188: 1485–1489.
Google Scholar | Crossref | Medline5. Fuchs, ME, DaJusta, DG. Robotics in pediatric urology. Int Braz J Urol 2020; 46: 322–327.
Google Scholar | Crossref | Medline6. Elder, JS, Diaz, M, Caldamone, AA, et al. Endoscopic therapy for vesicoureteral reflux: A meta-analysis. I. Reflux resolution and urinary tract infection. J Urol 2006; 175: 716–722.
Google Scholar | Crossref | Medline | ISI7. Routh, JC, Inman, BA, Reinberg, Y. Dextranomer/hyaluronic acid for pediatric vesicoureteral reflux: Systematic review. Pediatrics 2010; 125: 1010–1019.
Google Scholar | Crossref | Medline | ISI8. Lebowitz, RL, Olbing, H, Parkkulainen, KV, et al. International system of radiographic grading of vesicoureteric reflux. Pediatr Radiol 1985; 15: 105–109.
Google Scholar | Crossref | Medline | ISI9. Leung, L, Chan, IHY, Chung, PHY, et al. Endoscopic injection for primary vesicoureteric reflux: Predictors of resolution and long term efficacy. J Pediatr Surg 2017; 52: 2066–2069.
Google Scholar | Crossref | Medline10. Chung, KLY, Sihoe, J, Liu, K, et al. Surgical outcome analysis of pneumovesicoscopic ureteral reimplantation and endoscopic dextranomer/hyaluronic acid injection for primary vesicoureteral reflux in children: A multicenter 12-year review. J Laparoendosc Adv Surg Tech A 2018; 28: 348–353.
Google Scholar | Crossref | Medline11. Benoit, RM, Peele, PB, Docimo, SG. The cost-effectiveness of dextranomer/hyaluronic acid copolymer for the management of vesicoureteral reflux. 1: Substitution for surgical management. J Urol 2006; 176: 1588–1592.
Google Scholar | Crossref | Medline12. Saperston, K, Smith, J, Putman, S, et al. Endoscopic subureteral injection is not less expensive than outpatient open reimplantation for unilateral vesicoureteral reflux. J Urol 2008; 180: 1626–1629.
Google Scholar | Crossref | Medline13. Benoit, RM, Peele, PB, Cannon, GM, et al. The cost-effectiveness of dextranomer/hyaluronic acid copolymer for the management of vesicoureteral reflux. 2. Reflux correction at the time of diagnosis as a substitute for traditional management. J Urol 2006; 176: 2649–2653.
Google Scholar | Crossref | Medline14. Chertin, B, Prosolovich, K, Aharon, S, et al. Surgical reimplantation for the correction of vesicoureteral reflux following failed endoscopic injection. Adv Urol 2011; 2011: 352716.
Google Scholar | Crossref | Medline15. Hannula, A, Venhola, M, Renko, M, et al. Vesicoureteral reflux in children with suspected and proven urinary tract infection. Pediatr Nephrol 2010; 25: 1463–1469.
Google Scholar | Crossref | Medline | ISI16. Fast, AM, Nees, SN, Van Batavia, JP, et al. Outcomes of targeted treatment for vesicoureteral reflux in children with nonneurogenic lower urinary tract dysfunction. J Urol 2013; 190: 1028–1032.
Google Scholar | Crossref | Medline17. Peters, CA, Skoog, SJ, Arant, BS, et al. Summary of the AUA guideline on management of primary vesicoureteral reflux in children. J Urol 2010; 184: 1134–1144.
Google Scholar | Crossref | Medline18. Méndez, R, Somoza, I, Tellado, MG, et al. Predictive value of clinical factors for successful endoscopic correction of primary vesicoureteral reflux grades III-IV. J Pediatr Urol 2006; 2: 545–550.
Google Scholar | Crossref | Medline19. Choi, W, Nam, W, Lee, C, et al. Long-term outcomes of endoscopic anti-reflux surgery in pediatric patients with vesicoureteral reflux: Urinary tract infection, renal scarring, and predictive factors for success. J Korean Med Sci 2018; 33: e240.
Google Scholar | Crossref | Medline20. Lorenzo, AJ, Pippi Salle, JL, Barroso, U, et al. What are the most powerful determinants of endoscopic vesicoureteral reflux correction? Multivariate analysis of a single institution experience during 6 years. J Urol 2006; 176: 1851–1855.
Google Scholar | Crossref | Medline21. Lavelle, MT, Conlin, MJ, Skoog, SJ. Subureteral injection of Deflux for correction of reflux: Analysis of factors predicting success. Urology 2005; 65: 564–567.
Google Scholar | Crossref | Medline22. Alkan, M, Ciftci, AO, Senocak, ME, et al. Endoscopic treatment of vesicoureteral reflux in children: Our experience and analysis of factors affecting success rate. Urol Int 2008; 81: 41–46.
Google Scholar | Crossref | Medline23. Zambaiti, E, Pensabene, M, Montano, V, et al. Ultrasonographic mound height as predictor of vesicoureteral reflux resolution after endoscopic treatment in children. J Pediatr Surg 2016; 51: 1366–1369.
Google Scholar | Crossref | Medline24. Altug, U, Cakan, M, Yilmaz, S, et al. Are there predictive factors for the outcome of endoscopic treatment of grade III-V vesicoureteral reflux with dextranomer/hyaluronic acid in children? Pediatr Surg Int 2007; 23: 585–589.
Google Scholar | Crossref | Medline25. Kirsch, AJ, Arlen, AM, Leong, T, et al. Vesicoureteral reflux index (VURx): A novel tool to predict primary reflux improvement and resolution in children less than 2 years of age. J Pediatr Urol 2014; 10: 1249–1254.
Google Scholar | Crossref | Medline26. Coletta, R, Olivieri, C, Briganti, V, et al. Patients with a history of infection and voiding dysfunction are at risk for recurrence after successful endoscopic treatment of vesico ureteral reflux and deserve long-term follow up. Urol Ann 2012; 4: 19–23.
Google Scholar | Crossref | Medline27. Akin, Y, Gulmez, H, Güntekin, E, et al. Retrospective study of endoscopic treatment in children with primary vesicoureteral reflux and multivariate analysis of factors for failure. Scand J Urol 2014; 48: 565–570.
Google Scholar | Crossref | Medline

Comments (0)

No login
gif